Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

Adalimumab sustains steroid-free remission after 3 years of therapy for Crohn's disease.

Kamm MA, Hanauer SB, Panaccione R, Colombel JF, Sandborn WJ, Pollack PF, Zhou Q, Robinson AM. Adalimumab sustains steroid-free remission after 3 years of therapy for Crohn's disease. Aliment Pharmacol Ther. 2011 Aug; 34(3):306-17.

View in: PubMed

collapse authors with profiles